The chemokine receptor, CXCR2, mediates the tumorigenic effects of ELR+ CXC chemokines.
Keane
Michael P
MP
Lung Cancer SPORE at the David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA 90024-1922, USA. MPKeane@mednet.ucla.edu
Burdick
Marie D
MD
Xue
Ying Ying
YY
Lutz
Marin
M
Belperio
John A
JA
Strieter
Robert M
RM
D000818:Animals; D018827:Carcinoma, Lewis Lung / Q000098:blood supply* / Q000209:etiology; D002289:Carcinoma, Non-Small-Cell Lung / Q000098:blood supply / Q000209:etiology; D019743:Chemokines, CXC / Q000378:metabolism*; D008175:Lung Neoplasms; D051379:Mice; D008810:Mice, Inbred C57BL; D009389:Neovascularization, Pathologic / Q000209:etiology*; D023063:Receptors, Interleukin-8B / Q000502:physiology*
D019743:Chemokines, CXC; D023063:Receptors, Interleukin-8B